Literature DB >> 20205285

Prognostic factors in the surgical treatment of caudate lobe hepatocellular carcinoma.

Peng Liu1, Jia-Mei Yang, Wen-Yang Niu, Tong Kan, Feng Xie, Dian-Qi Li, Ye Wang, Yan-Ming Zhou.   

Abstract

AIM: To evaluate the short- and long-term outcomes of liver resection for caudate lobe hepatocellular carcinoma (HCC).
METHODS: We retrospectively analyzed 114 consecutive patients with HCC, originating from the caudate lobe, who underwent resection between January 2001 and January 2007. Univariate and multivariate analyses were performed on several clinicopathologic variables to determine the factors affecting long-term outcome and intrahepatic recurrence.
RESULTS: Overall mortality and morbidity were 0% and 18%, respectively. After a median follow-up of 31 mo (interquartile range, 11-66 mo), tumor recurrence had occurred in 76 patients (66.7%). The 1-, 3-, and 5-year disease-free survival rates were 65.7%, 38.1%, and 18.4%, respectively. The 1-, 3-, and 5-year overall survival rates were 76.1%, 54.7%, and 31.8%, respectively. Univariate analysis showed that subsegmental location of the tumor (45.7% vs 16.2%, P = 0.01), liver cirrhosis (12.3% vs 47.9%, P = 0.03), surgical margin (18.5% vs 54.6%, P = 0.04), vascular invasion (37.9% vs 23.2%, P = 0.04) and extended caudate resection (42.1% vs 15.4%, P = 0.04) were related to poorer long-term survival. Multivariate analysis showed that only subsegmental location of the tumor, liver cirrhosis and surgical margin were significant independent prognostic factors.
CONCLUSION: Hepatectomy was an effective treatment for HCC in the caudate lobe. The subsegmental location of the tumor, liver cirrhosis and surgical margin affected long-term survival.

Entities:  

Mesh:

Year:  2010        PMID: 20205285      PMCID: PMC2835791          DOI: 10.3748/wjg.v16.i9.1123

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  33 in total

1.  Prognostic factors and longterm survival after hepatic resection for hepatocellular carcinoma originating from noncirrhotic liver.

Authors:  Christophe Laurent; Jean Frédéric Blanc; Steeve Nobili; Antonio Sa Cunha; Brigitte le Bail; Paulette Bioulac-Sage; Charles Balabaud; Maylis Capdepont; Jean Saric
Journal:  J Am Coll Surg       Date:  2005-08-31       Impact factor: 6.113

2.  Multivariate and univariate analysis of prognostic factors following resection in HCC: the Birmingham experience.

Authors:  Abraham R John; Saboor Khan; Darius F Mirza; A David Mayer; John A C Buckels; Simon R Bramhall
Journal:  Dig Surg       Date:  2006-06-06       Impact factor: 2.588

3.  Outcome of patients with huge hepatocellular carcinoma after primary resection and treatment of recurrent lesions.

Authors:  S G Lee; S Hwang; J P Jung; Y J Lee; K H Kim; C S Ahn
Journal:  Br J Surg       Date:  2007-03       Impact factor: 6.939

4.  Early and late recurrence after liver resection for hepatocellular carcinoma: prognostic and therapeutic implications.

Authors:  Nazario Portolani; Arianna Coniglio; Sara Ghidoni; Mara Giovanelli; Anna Benetti; Guido Alberto Massimo Tiberio; Stefano Maria Giulini
Journal:  Ann Surg       Date:  2006-02       Impact factor: 12.969

5.  [Surgical treatment of hepatocellular carcinoma originating from caudate lobe].

Authors:  Shu-you Peng; Xue-dong Feng; Yin-bin Liu; Hao-ran Qian; Jiang-tao Li; Jian-wei Wang; Bin Xu; He-qing Fang; Li-ping Cao; Hong-wei Shen; Jian-jun Du; Xiu-jun Cai; Yi-ping Mu
Journal:  Zhonghua Wai Ke Za Zhi       Date:  2005-01-01

6.  Percutaneous radiofrequency ablation for the treatment of liver neoplasms in the caudate lobe left of the vena cava: electrode placement through the left lobe of the liver under CT-fluoroscopic guidance.

Authors:  Koichiro Yamakado; Atsuhiro Nakatsuka; Masao Akeboshi; Haruyuki Takaki; Kan Takeda
Journal:  Cardiovasc Intervent Radiol       Date:  2005 Sep-Oct       Impact factor: 2.740

7.  Surgical treatment of hepatocellular carcinoma originating from caudate lobe--a report of 39 cases.

Authors:  Shu You Peng; Jiang Tao Li; Ying Bin Liu; Xiu Jun Cai; Yi Ping Mou; Xue Dong Feng; Jian Wei Wang; Bin Xu; Hao Ran Qian; De Fei Hong; Xin Bao Wang; He Qing Fang; Li Ping Cao; Li Chen; Chen Hong Peng; Fu Bao Liu; Jian Feng Xue
Journal:  J Gastrointest Surg       Date:  2006-03       Impact factor: 3.452

8.  Anterior approach for complete isolated caudate lobectomy.

Authors:  Ji-Xiong Hu; Xiong-Ying Miao; De-Wu Zhong; Wei-Dong Dai; Wei Liu
Journal:  Hepatogastroenterology       Date:  2005 Nov-Dec

9.  Caudate hepatectomy for cancer: a single institution experience with 150 patients.

Authors:  William G Hawkins; Ronald P DeMatteo; Michael S Cohen; William R Jarnagin; Yuman Fong; Michael D'Angelica; Mithat Gonen; Leslie H Blumgart
Journal:  J Am Coll Surg       Date:  2005-03       Impact factor: 6.113

10.  Prognostic value and clinical relevance of the 6th Edition 2002 American Joint Committee on Cancer staging system in patients with resectable hepatocellular carcinoma.

Authors:  Hao-Jan Lei; Gar-Yang Chau; Wing-Yiu Lui; Shyh-Haw Tsay; Kuang-Liang King; Che-Chuan Loong; Chew-Wun Wu
Journal:  J Am Coll Surg       Date:  2006-08-23       Impact factor: 6.113

View more
  9 in total

1.  Prognoses and Clinicopathological Characteristics for Hepatocellular Carcinoma Originating from the Caudate Lobe After Surgery.

Authors:  Shingo Shimada; Toshiya Kamiyama; Hideki Yokoo; Tatsuya Orimo; Akihisa Nagatsu; Takanori Ohata; Hirofumi Kamachi; Akinobu Taketomi
Journal:  World J Surg       Date:  2019-04       Impact factor: 3.352

2.  Choice of approach for hepatectomy for hepatocellular carcinoma located in the caudate lobe: isolated or combined lobectomy?

Authors:  Peng Liu; Bao-An Qiu; Gang Bai; Hong-Wei Bai; Nian-Xin Xia; Ying-Xiang Yang; Jian-Yong Zhu; Yang An; Bing Hu
Journal:  World J Gastroenterol       Date:  2012-08-07       Impact factor: 5.742

3.  Prognostic value of cirrhosis for intrahepatic cholangiocarcinoma after surgical treatment.

Authors:  Ya-yong Li; Hao Li; Pin Lv; Gang Liu; Xiao-rong Li; Bu-ning Tian; Dao-jin Chen
Journal:  J Gastrointest Surg       Date:  2011-01-19       Impact factor: 3.452

4.  Long-term clinical outcomes of patients receiving proton beam therapy for caudate lobe hepatocellular carcinoma.

Authors:  Takashi Iizumi; Toshiyuki Okumura; Yuta Sekino; Hiroaki Takahashi; Yu-Lun Tsai; Daichi Takizawa; Toshiki Ishida; Yuichi Hiroshima; Masatoshi Nakamura; Shosei Shimizu; Takashi Saito; Haruko Numajiri; Masashi Mizumoto; Kei Nakai; Hideyuki Sakurai
Journal:  J Radiat Res       Date:  2021-07-10       Impact factor: 2.724

5.  A case of hepatocellular carcinoma in the caudate lobe successfully treated by transcatheter arterial chemoembolization using drug-eluting beads.

Authors:  Dong Hoo Joh; Jin Dong Kim; Young Nam Kim; Ha Hun Song; Hyun Kim; Kyung Ho Song; Sang Jin Lee; Jeong Rok Lee; Won Joong Jeon; Byung Hyo Cha
Journal:  Korean J Hepatol       Date:  2010-12

6.  Isolated caudate lobe resection: technical challenges.

Authors:  Sastha Ahanatha Pillai; Jeswanth Sathyanesan; Senthilkumar Perumal; Srinivasan Ulagendra Perumal; Anand Lakshmanan; Sukumar Ramaswami; Ravi Ramasamy; Ravichandran Palaniappan; Surendran Rajagopal
Journal:  Ann Gastroenterol       Date:  2013

7.  Caudate lobe resections: a single-center experience and evaluation of factors predictive of outcomes.

Authors:  Prejesh Philips; Russell W Farmer; Charles R Scoggins; Kelly M McMasters; Robert C G Martin
Journal:  World J Surg Oncol       Date:  2013-09-05       Impact factor: 2.754

8.  Multi-Institutional Retrospective Study of Radiotherapy for Hepatocellular Carcinoma in the Caudate Lobe.

Authors:  Sung Uk Lee; Sang Min Yoon; Jason Chia-Hsien Cheng; Tae Hyun Kim; Bo Hyun Kim; Jin-Hong Park; Jinhong Jung; Chiao-Ling Tsai; Yun Chiang; Joong-Won Park
Journal:  Front Oncol       Date:  2021-02-26       Impact factor: 6.244

9.  Sub-Classification of Cirrhosis Affects Surgical Outcomes for Early Hepatocellular Carcinoma Independent of Portal Hypertension.

Authors:  Er-Lei Zhang; Jiang Li; Jian Li; Wen-Qiang Wang; Jin Gu; Zhi-Yong Huang
Journal:  Front Oncol       Date:  2021-05-20       Impact factor: 6.244

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.